Document is current
Any future updates will be listed below
-
Authors
Sabato, Claudia
Noviello, Teresa Maria Rosaria
Covre, Alessia
Coral, Sandra
Caruso, Francesca Pia
Besharat, Zein Mersini
Splendiani, Elena
Masuelli, Laura
Battistelli, Cecilia
Vacca, Alessandra
Catanzaro, Giuseppina
Po, Agnese
Anichini, Andrea
Maio, Michele
Ceccarelli, Michele
Di Giacomo, Anna Maria
Ferretti, Elisabetta https://orcid.org/0000-0001-7265-6429
-
Funding
Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2017XJ38A4_004)
Associazione Italiana per la Ricerca sul Cancro (21846, 21073)
Ministero della Salute (NET-2016-02361632)
- License Information
-
More Information
Article History
Received: 15 July 2022
Accepted: 25 September 2022
First Online: 15 October 2022
Declarations
:
: Ethical approval was obtained from the University Hospital of Siena (Siena, Italy) (European 221 Union Drug Regulating Authorities Clinical Trials, number 2012–222004301–27 and with ClinicalTrials.gov Identifier number NCT02608437. ClinicalTrials.gov Identifier Number NCT02460068) and Sapienza University of Rome (Ethics Committee number 5943). All studies were conducted in accordance with the Declaration of Helsinki 1964 and its later amendments. All participating patients and subjects provided signed-informed consent before enrollment.
: The authors declare that they have no competing interests.
: The authors state no conflict of interest.
